On a preliminary basis, Integra LifeSciences Holdings (NASDAQ:IART) expects Q1 revenue of $352M – 354M, down almost 2% from a year ago on a reported basis and shy of consensus of $367M.
Q2 will be worse due to COVID-19 disruptions.
Management will update investors on May 7 during its Q1 earnings call.
https://seekingalpha.com/news/3559115-integra-lifesciences-sees-drop-in-q1-revenue-amid-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.